Browse Guides  internal medicine  infectious disease

Cellulitis

Prevalence
Clinical features
Differential Diagnosis
Investigations
Therapy
Prevention
Prognosis
Therapy

Consider granulocyte colony-stimulating factor in patients with diabetes who require admission. a  

Why?

  • More patients are cured, particularly with leg ulcers and fewer require surgery. a
  • Patients spend less time in hospital (on average 8 days fewer). a

Granulocyte colony stimulating factor speeds healing in extensive diabetic cellulitis

Patient a Treatment Comparison Outcome CER RRR
(95% CI)
NNT
(95% CI)
diabetes and extensive cellulitis   granulocyte colony stimulating factor placebo surgery
at at discharge
20% 100%
5
(3 to 40)
      persistent cellulitis
at 7 days
80% 44%
(4% to 67%)
3
(2 to 14)
      persistent ulcer 100% 20%
(0% to 36%)
5
(3 to 40)

 

Expiry date: January 2004
Levels of Evidence used in grading these guides

Authors   J   Epling , CM   Ball
Reviewer   C   Conlon
CAT Writers   J   Epling , CM   Ball